Abiomed (ABMD -6.4%) trades down today coming off a 2-day trading halt, touching a 52-week low...
Abiomed (ABMD -6.4%) trades down today coming off a 2-day trading halt, touching a 52-week low of $11.80 after the company announced that the FDA Circulatory System Devices Panel voted to retain Class III status for the temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category - which includes ABMD's Impella - rather than the lower-risk Class II category it had hoped for.
From other sites
at CNBC.com (Mar 24, 2015)
at CNBC.com (Nov 6, 2013)
at CNBC.com (Apr 17, 2013)
at CNBC.com (Mar 13, 2013)
at CNBC.com (Dec 12, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs